Images List Premium Download Classic

Intraperitoneal

Intraperitoneal-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Intraperitoneal chemotherapy medical devices, kits, and methods
Cook Medical Technologies Llc
June 08, 2017 - N°20170157359

Medical devices useful in the delivery of chemotherapeutic agents, kits and methods are described. An example catheter comprises an elongate member having an elongate member proximal end, an elongate member distal end, and an elongate member main body extending between the elongate member proximal end and the elongate member distal end. The elongate member main body defines an elongate member ...
Medical treatment system and methods using a plurality of fluid lines
Deka Products Limited Partnership
June 08, 2017 - N°20170157310

A medical treatment system, such as peritoneal dialysis system, may include control and other features to enhance patient comfort and ease of use. For example, a peritoneal dialysis system may include a control system that can adjust the volume of fluid infused into the peritoneal cavity to prevent the intraperitoneal fluid volume from exceeding a pre-determined amount. The control system ...
Blood glucose control system
The General Hospital Corporation
April 06, 2017 - N°20170095612

Techniques are used for adaptation of drug-administration parameters that control insulin delivery in a blood glucose control system. One technique provides long-term adaptation of a nominal basal infusion rate, adapting to longer-term changes in a patient's needs due to growth, illness, hormonal fluctuations, physical activity, aging, etc. Another technique provides adaptation of priming dose size at mealtimes for overall better ...
Intraperitoneal Patent Pack
Download + patent application PDFs
Intraperitoneal Patent Applications
Download + Intraperitoneal-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Intraperitoneal-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Neo-islets comprising stem and islet cells and treatment of diabetes mellitus therewith
Symbiocelltech, Llc
March 16, 2017 - N°20170073641

Described are neo-islets comprising: a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells where the cells have been treated so as to facilitate redifferentiation. Further described herein are methods of generating neo-islets, the methods comprising: culturing a) dedifferentiated islet cells and mesenchymal and/or adipose stem ...
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
Contrafect Corporation
January 05, 2017 - N°20170002062

The present invention provides methods for treatment or prophylaxis of viruses, particularly influenza virus, by administration of agents, particularly neutralizing antibodies or active fragments thereof, directly to the respiratory tract, including by intranasal or inhalation administration. The invention provides compositions suitable for intranasal or inhalation treatment and administration. The invention includes methods for treatment or prophylaxis combining intranasal or inhalation ...
Methods for producing high concentration lyophilized pharmaceutical formulations
Merck Sharp & Dohme Corp.
December 29, 2016 - N°20160375133

The present invention relates to methods of producing lyophilized pharmaceutical compositions comprising a high concentration of therapeutic protein or antibody prior to lyophilization, wherein the lyophilized formulation can be reconstituted with a diluent in about 15 minutes or less. The invention also relates to the high concentration lyophilized formulations produced by the methods described herein. The lyophilized formulations produced by the ...
Intraperitoneal Patent Pack
Download + patent application PDFs
Intraperitoneal Patent Applications
Download + Intraperitoneal-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Intraperitoneal-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Electromyography with prosthetic or orthotic devices
Össur Iceland Ehf
October 20, 2016 - N°20160302686

Systems, devices and methods for control of a prosthetic or orthotic device (pod) based on electromyography (emg) signals are described. The pod may be a lower or upper limb pod having one or more joints. One or more emg sensors may detect the emg signals. The emg sensors may be external, subcutaneous, intraperitoneal, epimysial, intramuscular, or other types. Control of ...
Method and system for producing and delivering airless medical ice slurry to induce hypothemia
Össur Iceland Ehf
June 23, 2016 - N°20160175141

The present invention relates to a method and system for producing and delivering sterile, airless, and highly loaded ice slurry for inducing therapeutic hypothermia. The method is capable of producing and delivering ice slurry in a patient to induce hypothermia through internal and external cooling methods such as subcutaneous, intravascular, intraperitoneal, gastrointestinal, and lung methods. The method is capable of ...
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
Insmed Incorporated
June 16, 2016 - N°20160166608

One aspect of the invention relates to methods of treating cancer in a patient comprising administering intraperitoneally to a patient in need thereof a cancer treating effective amount of a composition comprising a lipid-complexed platinum compound wherein the concentration of the platinum compound of the lipid-complexed platinum compound composition is greater than about 1. 2 mg/ml. Another aspect of the invention ...
Method for inducing artificial ovulation and spawning of fresh-water eels
Googol Holdings Co., Ltd
May 19, 2016 - N°20160135436

According to an example, artificial ovulation and spawning of freshwater eels may be induced to promote artificial ovulation without employing intraperitoneal injection, by feeding a feminization-inducing material (e. G., 17β-estradiol) for inducing feminization during a predetermined period into a raising bath in which broodfish are raised and, when an ovulation induction period arrives, adding pituitary extracts of catadromous ...
Medical treatment system and methods using a plurality of fluid lines
Googol Holdings Co., Ltd
April 14, 2016 - N°20160101278

Improvements in fluid volume measurement systems are disclosed for a pneumatically actuated diaphragm pump in general, and a peritoneal dialysis cycler using a pump cassette in particular. Pump fluid volume measurements are based on pressure measurements in a pump control chamber and a reference chamber in a two-chamber model, with different sections of the apparatus being modeled using a combination ...
Method and system providing more accurate fluid temperature monitoring with selectable fluid input and output ...
Googol Holdings Co., Ltd
April 14, 2016 - N°20160101228

Arrangements of components for use in support of a hyperthermic intraperitoneal chemotherapy (hipec) system which conveys fluids from a system to a patient and back to the system in a complete circuit. The described arrangements provide multiple means of rapidly configuring the number of input lines and output lines into and out of the patient. Included are integral temperature probes ...
Medical treatment system and methods using a plurality of fluid lines
Googol Holdings Co., Ltd
April 14, 2016 - N°20160101227

Improvements in fluid volume measurement systems are disclosed for a pneumatically actuated diaphragm pump in general, and a peritoneal dialysis cycler using a pump cassette in particular. Pump fluid volume measurements are based on pressure measurements in a pump control chamber and a reference chamber in a two-chamber model, with different sections of the apparatus being modeled using a combination ...
Intraperitoneal Patent Pack
Download + patent application PDFs
Intraperitoneal Patent Applications
Download + Intraperitoneal-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Intraperitoneal-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Site 2 insulin analogues
Case Western Reserve University
March 24, 2016 - N°20160083448

An insulin analogue contains one or more modifications at a distinct protein surface comprising one or more of the residues at position b13, b17, a12, a13, and/or a17. Formulations of the above analogues at successive strengths u-100 to u-1000 in soluble solutions a at least ph value in the range 6. 8-8. 0 either in the presence of zinc ions at ...
Medical treatment system and methods using a plurality of fluid lines
Deka Products Limited Partnership
March 24, 2016 - N°20160082173

A medical treatment system, such as peritoneal dialysis system, may include control and other features to enhance patient comfort and ease of use. For example, a peritoneal dialysis system may include a control system that can adjust the volume of fluid infused into the peritoneal cavity to prevent the intraperitoneal fluid volume from exceeding a pre-determined amount. The control system ...
Use of the pat nonapeptide in the treatment and prevention of neurodegenerative diseases
Orphit
March 17, 2016 - N°20160074463

A pat nonapeptide of formula eaksqggsd can be used to treat or prevent neurodegenerative diseases such as alzheimer's disease, parkinson's disease, huntington's disease and amyotrophic lateral sclerosis. Pharmaceutical compositions containing the pat nonapeptide can be formulated for administration by parenteral route, including the subcutaneous, intraperitoneal, intravenous or intranasal routes.
Targeted polymeric inflammation-resolving nanoparticles
The Trustees Of Columbia University
January 28, 2016 - N°20160022835

Sub-100 micron multimodal nanoparticles have four main components: 1) a target element (peptides, lipids, antibodies, small molecules, etc.) that can selectively bind to cells, tissues, or organs of the body; 2) a diagnostic agent such as a fluorophore or nmr contrast agent that allows visualization of nanoparticles at the site of delivery and/or a therapeutic or prophylactic agent; 3) an outside ȁ...
Methods for reducing fibrosis induced by peritoneal dialysis
Saint Louis University
December 24, 2015 - N°20150366952

The disclosure relates to a method of preventing, inhibiting, or reducing fibrosis, the incidence of fibrosis or the progression of fibrosis associated with peritoneal dialysis, during or after peritoneal is administered. More specifically, the methods relates to using intraperitoneal administration of activated protein c (apc) possessing cytoprotective or anti-inflammatory activity, to reduce the incidence or progression of fibrosis associated with ...
Pharmaceutical composition containing conventional liposomes and prolonged-circulation liposomes for the treatment of visceral leishmaniasis
FundaÇao De Amparo A Pesquisa Do Estado De Minas Gerais- Fapemig
October 29, 2015 - N°20150306035

The present invention relates to a pharmaceutical composition for treating visceral leishmaniasis, characterized in that it comprises the association of conventional liposomes and prolonged-circulation liposomes with a leishmanicidal-drug delivery system. Said composition may be used in the preparation of a medicinal product for treating leishmaniasis and may be administered intramuscularly, subcutaneously, intraperitoneally or intravenously. The use of this system enables ...
Reducing post-operative adhesion formation with intraperitoneal glutamine
Ade Therapeutics Inc.
September 10, 2015 - N°20150250928

Intraperitoneal administration of glutamine to reduce adhesions in the peritoneum of a patient.
Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
Yale University
August 06, 2015 - N°20150218644

The invention discloses high levels of receptors for clostridium perfringens enterotoxin (cpe) have been found in ovarian cancer and uterine cancer tissue samples. In addition, successful in vivo treatment of a mouse model of ovarian cancer with intraperitoneal injection of cpe is disclosed. High levels of ep-cam protein is also disclosed in ovarian cancer tissue samples. Thus, the invention provides ...
Loading